Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Biotechnology

Healthcare
$18.98 -0.05%

-$0.01 today

Market cap
$912.33M
Beta
0.00
52W Low $15.35High $20.30

Volume 0.37M

Average 0.43M

ODTX Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

No reported Capital Expenditures figures are available to summarize.

Capital Expenditures history

Currency unavailable · from the cash flow

No Capital Expenditures data reported for this period type.

Capital Expenditures vs competitors

How ODTX compares with its peers on the latest reported figures

ODTX Competitors
Capital Expenditures for ODTX and competitors
Company Period LTM YoY 3-year CAGR% of revenue
PTGXProtagonist Therapeutics, Inc.LTM Jun 2026$975K USD+139.9%+26.0%0.3%
ALMSAlumis Inc. Common StockLTM Jun 2026$401K USD-77.7%-35.3%5.4%
ORKAOruka Therapeutics, Inc.LTM Sep 2026$219K USD+33.5%+371.0%—
IMUXImmunic, Inc.LTM Mar 2026$116K USD-58.6%+12.9%—
ACRSAclaris Therapeutics, Inc.LTM Mar 2026$81K USD-99.8%-43.2%1.0%
ANABAnaptysBio, Inc.LTM Mar 2026$69K USD-81.1%-37.6%0.0%
SYRESpyre Therapeutics, Inc.LTM Sep 2026$0 USD——0.0%
ODTXOdyssey Therapeutics, Inc.—— ———
AGMBAgomAb Therapeutics N.V. American Depositary Shares—— ———
Peer median (excluding ODTX) —-68.1%-11.2%0.3%

Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Odyssey Therapeutics, Inc.

NASDAQ:ODTX

Intrinsic Alpha fair value

Locked

Current Price

$18.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.